Versican

Versican is a **large chondroitin sulfate proteoglycan** found abundantly in the extracellular matrix of many tissues. It is encoded by the *VCAN* gene and belongs to the lectican family alongside aggrecan, brevican, and neurocan[1]. Versican exists in multiple isoforms—V0, V1, V2, V3, V4—generated by alternative splicing. These isoforms differ by their glycosaminoglycan attachment domains and have distinct biological activities; for example, **V1 promotes cell proliferation and inhibits apoptosis**, while **V2 has antiproliferative effects**[3][4]. Functionally versatile (“versatile” being the root of its name), versican regulates **cell adhesion** (often acting as an antiadhesive molecule), migration during embryonic development or wound healing processes, angiogenesis during tissue repair or tumorigenesis, immune responses through modulation of inflammation pathways,[4] and maintenance of extracellular matrix integrity via interactions with hyaluronan.[1] Versican’s dysregulation has been implicated in several diseases including various cancers—where it can either promote or inhibit tumor progression depending on context—inflammatory conditions due to its upregulation during immune responses,[4] cardiovascular pathologies involving vascular smooth muscle cells,[1] neurodevelopmental disorders,[4] and genetic syndromes such as Wagner syndrome caused by mutations affecting isoform balance within ocular tissues.[2] Currently there are no approved drugs that specifically target versican directly nor established clinical biomarkers based solely on its expression levels. Its complex biology makes it both an important research focus for understanding tissue remodeling/disease mechanisms but also presents challenges for therapeutic intervention without off-target effects.[5]

Other names

Chondroitin sulfate proteoglycan 2CSPG2PG-MChondroitin sulfate proteoglycan core protein 2

null; no approved drugs directly target versican as a primary mechanism. Its role is more as a modulator in the extracellular matrix affecting cell behavior rather than being a direct drug target at present.